BERNARDS RENE purchased 11.1% of their position (15K shares) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $7.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/16/2022ACC: 0001493152-22-035794
Director
Since Jun 2022
+15K
Net shares
Net buyer
$7.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$0.51
Trade value
$7.65K
% of position
11.1%
12/15/2022
135K→150K
Total
Net shares
+15K
Net value
$7.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2022 | P · Purchase | +15K | $0.51 | $7.65K | 11.1% | 135K | 150K |
| Total | +15K | $7.65K | ||||||
Derivative Transactions0
No derivative transactions reported